
Jean F. Voltaire
Examiner (ID: 18083, Phone: (571)272-3953 , Office: P/2466 )
| Most Active Art Unit | 2466 |
| Art Unit(s) | 2466, 2417 |
| Total Applications | 487 |
| Issued Applications | 381 |
| Pending Applications | 55 |
| Abandoned Applications | 68 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6223403
[patent_doc_number] => 20100056619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'Chroman-Derived Anti-Androgens For Treatment of Androgen-Mediated Disorders'
[patent_app_type] => utility
[patent_app_number] => 12/581501
[patent_app_country] => US
[patent_app_date] => 2009-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14371
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0056/20100056619.pdf
[firstpage_image] =>[orig_patent_app_number] => 12581501
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/581501 | Chroman-Derived Anti-Androgens For Treatment of Androgen-Mediated Disorders | Oct 18, 2009 | Abandoned |
Array
(
[id] => 6638525
[patent_doc_number] => 20100035982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'OXALIPLATIN FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/581624
[patent_app_country] => US
[patent_app_date] => 2009-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6823
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20100035982.pdf
[firstpage_image] =>[orig_patent_app_number] => 12581624
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/581624 | OXALIPLATIN FORMULATIONS | Oct 18, 2009 | Abandoned |
Array
(
[id] => 6039531
[patent_doc_number] => 20110092580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'Docetaxel formulations with lipoic acid and/or dihydrolipoic acid'
[patent_app_type] => utility
[patent_app_number] => 12/589145
[patent_app_country] => US
[patent_app_date] => 2009-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15721
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20110092580.pdf
[firstpage_image] =>[orig_patent_app_number] => 12589145
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/589145 | Docetaxel formulations with lipoic acid and/or dihydrolipoic acid | Oct 18, 2009 | Issued |
Array
(
[id] => 6615766
[patent_doc_number] => 20100099683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'COMPOUNDS THAT INHIBIT HUMAN DNA LIGASES AND METHODS OF TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/576410
[patent_app_country] => US
[patent_app_date] => 2009-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 22271
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20100099683.pdf
[firstpage_image] =>[orig_patent_app_number] => 12576410
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/576410 | Compounds that inhibit human DNA ligases and methods of treating cancer | Oct 8, 2009 | Issued |
Array
(
[id] => 6576300
[patent_doc_number] => 20100129470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'METHOD OF TREATING BRAIN CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/575922
[patent_app_country] => US
[patent_app_date] => 2009-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5862
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20100129470.pdf
[firstpage_image] =>[orig_patent_app_number] => 12575922
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/575922 | METHOD OF TREATING BRAIN CANCER | Oct 7, 2009 | Abandoned |
Array
(
[id] => 6359934
[patent_doc_number] => 20100087457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-08
[patent_title] => 'DOSAGES AND METHODS FOR THE TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/575110
[patent_app_country] => US
[patent_app_date] => 2009-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6380
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20100087457.pdf
[firstpage_image] =>[orig_patent_app_number] => 12575110
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/575110 | DOSAGES AND METHODS FOR THE TREATMENT OF CANCER | Oct 6, 2009 | Abandoned |
Array
(
[id] => 6494789
[patent_doc_number] => 20100093773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'METHODS OF TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/574632
[patent_app_country] => US
[patent_app_date] => 2009-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6997
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20100093773.pdf
[firstpage_image] =>[orig_patent_app_number] => 12574632
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/574632 | METHODS OF TREATING CANCER | Oct 5, 2009 | Abandoned |
Array
(
[id] => 10850495
[patent_doc_number] => 08877173
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-04
[patent_title] => 'Weather resistant granular slug, snail and insect bait'
[patent_app_type] => utility
[patent_app_number] => 12/572309
[patent_app_country] => US
[patent_app_date] => 2009-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 5618
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 249
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12572309
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/572309 | Weather resistant granular slug, snail and insect bait | Oct 1, 2009 | Issued |
Array
(
[id] => 6359243
[patent_doc_number] => 20100087399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-08
[patent_title] => 'USE OF 9-OXOACRIDINE-10-ACETIC ACID, SALTS AND ESTERS THEREOF IN COMBINATION THERAPY OF OVARIAN CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/569112
[patent_app_country] => US
[patent_app_date] => 2009-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9755
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20100087399.pdf
[firstpage_image] =>[orig_patent_app_number] => 12569112
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/569112 | USE OF 9-OXOACRIDINE-10-ACETIC ACID, SALTS AND ESTERS THEREOF IN COMBINATION THERAPY OF OVARIAN CANCER | Sep 28, 2009 | Abandoned |
Array
(
[id] => 6538261
[patent_doc_number] => 20100204279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'Therapeutic Salt Compositions and Methods'
[patent_app_type] => utility
[patent_app_number] => 12/563570
[patent_app_country] => US
[patent_app_date] => 2009-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2465
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20100204279.pdf
[firstpage_image] =>[orig_patent_app_number] => 12563570
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/563570 | Therapeutic Salt Compositions and Methods | Sep 20, 2009 | Abandoned |
Array
(
[id] => 10844624
[patent_doc_number] => 08871800
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-28
[patent_title] => 'Statin and omega-3 fatty acids for reduction of Apo-B levels'
[patent_app_type] => utility
[patent_app_number] => 12/561558
[patent_app_country] => US
[patent_app_date] => 2009-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10326
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 283
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12561558
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/561558 | Statin and omega-3 fatty acids for reduction of Apo-B levels | Sep 16, 2009 | Issued |
Array
(
[id] => 6401454
[patent_doc_number] => 20100179142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-15
[patent_title] => 'Cancer Combination Therapy Comprising AZD2171 and ZD1839'
[patent_app_type] => utility
[patent_app_number] => 12/555592
[patent_app_country] => US
[patent_app_date] => 2009-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7423
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0179/20100179142.pdf
[firstpage_image] =>[orig_patent_app_number] => 12555592
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/555592 | Cancer Combination Therapy Comprising AZD2171 and ZD1839 | Sep 7, 2009 | Abandoned |
Array
(
[id] => 6631851
[patent_doc_number] => 20100311804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'USE OF INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE IN COMBINATION WITH OTHER THERAPEUTIC MODALITIES'
[patent_app_type] => utility
[patent_app_number] => 12/548657
[patent_app_country] => US
[patent_app_date] => 2009-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 20438
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20100311804.pdf
[firstpage_image] =>[orig_patent_app_number] => 12548657
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/548657 | Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities | Aug 26, 2009 | Issued |
Array
(
[id] => 8932683
[patent_doc_number] => 08492383
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-23
[patent_title] => 'Combination of a nitrogen mustard analogue and imatinib for treatment of chronic lymphocytic leukemia'
[patent_app_type] => utility
[patent_app_number] => 12/543868
[patent_app_country] => US
[patent_app_date] => 2009-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5191
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12543868
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/543868 | Combination of a nitrogen mustard analogue and imatinib for treatment of chronic lymphocytic leukemia | Aug 18, 2009 | Issued |
Array
(
[id] => 6598492
[patent_doc_number] => 20100048709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'Treatment of Prostate Cancer with DDC Inhibitor'
[patent_app_type] => utility
[patent_app_number] => 12/537895
[patent_app_country] => US
[patent_app_date] => 2009-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17389
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20100048709.pdf
[firstpage_image] =>[orig_patent_app_number] => 12537895
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/537895 | Treatment of prostate cancer with DDC inhibitor | Aug 6, 2009 | Issued |
Array
(
[id] => 6224616
[patent_doc_number] => 20100056983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'Treatment of cancer using photodynamic therapy'
[patent_app_type] => utility
[patent_app_number] => 12/462606
[patent_app_country] => US
[patent_app_date] => 2009-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2986
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0056/20100056983.pdf
[firstpage_image] =>[orig_patent_app_number] => 12462606
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/462606 | Treatment of cancer using photodynamic therapy | Aug 5, 2009 | Abandoned |
Array
(
[id] => 8555275
[patent_doc_number] => 08329747
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-11
[patent_title] => 'Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/535048
[patent_app_country] => US
[patent_app_date] => 2009-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 8635
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12535048
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/535048 | Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof | Aug 3, 2009 | Issued |
Array
(
[id] => 6321075
[patent_doc_number] => 20100113474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'Antineoplastic Combinations of 4-Anilino-3-Cyanoquinolines and Capecitabine'
[patent_app_type] => utility
[patent_app_number] => 12/534895
[patent_app_country] => US
[patent_app_date] => 2009-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12350
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20100113474.pdf
[firstpage_image] =>[orig_patent_app_number] => 12534895
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/534895 | Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine | Aug 3, 2009 | Issued |
Array
(
[id] => 5552879
[patent_doc_number] => 20090286865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-19
[patent_title] => 'POTENTIATOR OF ANTITUMORAL AGENTS IN THE TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/510196
[patent_app_country] => US
[patent_app_date] => 2009-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2823
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20090286865.pdf
[firstpage_image] =>[orig_patent_app_number] => 12510196
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/510196 | POTENTIATOR OF ANTITUMORAL AGENTS IN THE TREATMENT OF CANCER | Jul 26, 2009 | Abandoned |
Array
(
[id] => 8152208
[patent_doc_number] => 08168662
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2012-05-01
[patent_title] => 'Use of picoplatin to treat colorectal cancer'
[patent_app_type] => utility
[patent_app_number] => 12/508372
[patent_app_country] => US
[patent_app_date] => 2009-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5603
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/168/08168662.pdf
[firstpage_image] =>[orig_patent_app_number] => 12508372
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/508372 | Use of picoplatin to treat colorectal cancer | Jul 22, 2009 | Issued |